Psychologists in Havelock, NC Accepting Medicare
6 Psychologists found. Showing 1 - 6
 Dr. Allison Clark, PH.D., ABPP Psychologist Medicare: Medicare Enrolled Practice Location: 4389 Beaufort Road, Havelock, NC 28532 Phone: 252-466-0500 |
Dr. Isabelle B Ragsdale, PH. D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 156 Us Highway 70 W, Havelock, NC 28532 Phone: 252-447-8907 Fax: 252-444-0923 |
Julia Eva Von Heeringen, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4389 Beaufort Rd, Havelock, NC 28532 Phone: 252-466-0500 |
 Dr. Christopher Thomas Blair, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: Naval Hospital Cherry Point, Psychology Department, Havelock, NC 28533 Phone: 252-466-0504 |
Leif C. Crowe, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 318a E Main St, Havelock, NC 28532 Phone: 252-444-1711 Fax: 252-444-0809 |
Dr. Patricia S Dickinson, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 318a E Main St, Havelock, NC 28532 Phone: 252-447-7764 Fax: 252-444-6800 |
News Archive
The mechanism behind protective cells protecting themselves
Researchers at St. Jude Children's Research Hospital have discovered the mechanism by which immune cells called regulatory T cells keep themselves intact and functional during their demanding task of holding the immune system in check. Such T cells are key to preventing the immune system from attacking the body in autoimmune disease.
Germicidal lamps used to sanitize against COVID-19 may damage the cornea
In a paper published in the journal of Ocular Immunology and Inflammation, physicians from the Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine reported that several patients using germicidal lamps in an attempt to sanitize against the coronavirus.
Rocket Pharma partners with Stanford University to advance FA and PKD gene therapy research
Rocket Pharmaceuticals, Inc., a leading U.S.-based multi-platform gene therapy company, and the Stanford University School of Medicine today announced a strategic collaboration to support the advancement of Fanconi Anemia and Pyruvate Kinase Deficiency gene therapy research.
NASDAQ Panel grants NexMed extension to meet remaining listing requirements
NexMed, Inc., a specialty CRO and a developer of products based on the NexACT technology, today announced that the NASDAQ Listing Qualifications Panel (the "Panel") has determined that NexMed has evidenced compliance with the market value of listed securities requirement for continued listing on The NASDAQ Capital Market by evidencing a market capitalization in excess of $35 million for a minimum of ten consecutive trading days, in lieu of the $2.5 million in stockholder's equity as required by the Panel's decision dated December 17, 2009.
› Verified 5 days ago
Pharmacists
Dentists
Counselors
Clinical Social Workers
Psychologists
Occupational Therapists